China bird flu toll reaches nine
SHANGHAI (Reuters) - The death toll in China from a new strain of bird flu rose to nine on Tuesday, said state media, who also quoted Chinese authorities saying a vaccine should be ready within months. (Source: Reuters: Health)
Source: Reuters: Health - April 10, 2013 Category: Consumer Health News Tags: healthNews Source Type: news

IDRI and Medicago to present data at the World Vaccine Congress
(Infectious Disease Research Institute) IDRI, a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, will present positive interim Phase I clinical results for their H5N1 Avian Influenza VLP vaccine candidate. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 9, 2013 Category: Global & Universal Source Type: news

Bird flu mutation study offers vaccine clue
(Imperial College London) Scientists have described small genetic changes that enable the H5N1 bird flu virus to replicate more easily in the noses of mammals. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 8, 2013 Category: Global & Universal Source Type: news

CDC on Trail of Vaccine for New Bird Flu
(MedPage Today) -- As the number of cases of a novel bird flu rises in China, the CDC is taking early steps toward a vaccine. (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - April 5, 2013 Category: Infectious Diseases Source Type: news

C.D.C. Has Begun Work on Vaccine for New China Flu
Health officials say that as a precaution they are formulating a vaccine for the mysterious new H7N9 flu. (Source: NYT Health)
Source: NYT Health - April 5, 2013 Category: Consumer Health News Authors: By DONALD G. McNEIL Jr. and ANDREW JACOBS Tags: Centers for Disease Control and Prevention Avian Influenza China Vaccination and Immunization Source Type: news

CDC Monitoring Bird Flu, Prepping Vaccine Just in Case
The Centers for Disease Control and Prevention (CDC) said on Thursday it was monitoring a new strain of bird flu and has started work on a vaccine just in case it is needed. So far, the strain known as avian influenza A (H7N9) has only been found in China and does not appear to be capable of being passed from person to person. (Source: RWJF News Digest - Public Health)
Source: RWJF News Digest - Public Health - April 5, 2013 Category: American Health Source Type: news

US Says Following New Flu Closely, Preparing VaccineUS Says Following New Flu Closely, Preparing Vaccine
The U.S. Centers for Disease Control and Prevention (CDC) said on Thursday it was monitoring a new strain of bird flu and has started work on a vaccine just in case it is needed. Reuters Health Information (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 5, 2013 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

U.S. says following new bird flu closely, preparing vaccine
CHICAGO (Reuters) - The U.S. Centers for Disease Control and Prevention (CDC) said on Thursday it was monitoring a new strain of bird flu and has started work on a vaccine just in case it is needed. (Source: Reuters: Health)
Source: Reuters: Health - April 4, 2013 Category: Consumer Health News Tags: healthNews Source Type: news

U.S. Says Following New Bird Flu Closely, Preparing Vaccine
The U.S. Centers for Disease Control and Prevention (CDC) said on Thursday it was monitoring a new strain of bird flu and has started work on a vaccine just in case it is needed.Source: Reuters Health Related MedlinePlus Page: Bird Flu (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - April 4, 2013 Category: Consumer Health News Source Type: news

World Experts Debate Case for New Bird Flu VaccineWorld Experts Debate Case for New Bird Flu Vaccine
Experts from around the world are in daily talks about the threat posed by a deadly new strain of bird flu in China, including discussions on if and when to start making a vaccine. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 4, 2013 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Clinical Notes: Bird Flu Vaccine Delayed at FDA
(MedPage Today) -- An "administrative matter" blocked approval of a vaccine against potentially pandemic avian influenza, its manufacturer said. Also this week: smokers with lung cancer don't get help in quitting. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 31, 2013 Category: Dermatology Source Type: news

Newly Designed Vaccine Blocks H5 Avian Influenza In Animal Models
Until now most experimental vaccines against the highly lethal H5N1 avian influenza virus have lacked effectiveness. But a new vaccine has proven highly effective against the virus when tested in both mice and ferrets. It is also effective against the H9 subtype of avian influenza. The research is published online ahead of print in the Journal of Virology. The strength of the new vaccine is that it uses attenuated, rather than "killed" virus. (Killed viruses are broken apart with chemicals or heat, and they are used because they are safer than attenuated viruses... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 27, 2013 Category: Consumer Health News Tags: Bird Flu / Avian Flu Source Type: news

FDA delays approval of GSK bird flu vaccine
LONDON (Reuters) - Regulators have delayed approval of an H5N1 bird flu vaccine from GlaxoSmithKline, designed to be used in a pandemic. (Source: Reuters: Health)
Source: Reuters: Health - March 25, 2013 Category: Consumer Health News Tags: healthNews Source Type: news

Regulatory update: GlaxoSmithKline receives complete response from FDA for candidate pandemic H5N1 adjuvanted influenza vaccine
GlaxoSmithKline [NYSE:GSK] announced today that it has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) in response to the Biologics License Application (BLA) for its Pandemic Influenza A Virus Monovalent Adjuvanted candidate vaccine, referred to as Q-Pan H5N1. (Source: GSK news)
Source: GSK news - March 25, 2013 Category: Pharmaceuticals Source Type: news

Cleverly designed vaccine blocks H5 avian influenza in models
(American Society for Microbiology) Until now, most experimental vaccines against the highly lethal H5N1 avian influenza virus have lacked effectiveness. But a new vaccine has proven highly effective against the virus when tested in both mice and ferrets. It is also effective against the H9 subtype of avian influenza. The research is published online ahead of print in the Journal of Virology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 25, 2013 Category: Global & Universal Source Type: news